Lamine Hamzaoui
Lamine Hamzaoui has a total of 610 co-authors. Here are the top co-authors by number of shared publications:
Moufida Mahmoudi
Gastroenterology Department, Mohamed Taher Maamouri University Hospital Nabeul, Mrezga, Nabeul
10 shared publicationsMouna Medhioub
Gastroenterology Department, Mohamed Taher Maamouri University Hospital Nabeul, Mrezga, Nabeul
10 shared publicationsEmna Chelbi
Pathology Department, Mohamed Taher Maamouri University Hospital Nabeul, Mrezga, Nabeul
8 shared publications- Amal Khsiba
Gastroenterology Department, Mohamed Taher Maamouri University Hospital Nabeul, Mrezga, Nabeul
7 shared publications Asma Ben Mohamed
Gastroenterology Department, Mohamed Taher Maamouri University Hospital Nabeul, Mrezga, Nabeul
6 shared publicationsManel Yakoubi
Gastroenterology Department, Mohamed Taher Maamouri University Hospital Nabeul, Mrezga, Nabeul
5 shared publications
Latest Publications
- Open Access
- 3 July 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1019
Case Report: Overlooked Skin Melanoma Unveiled by Gastric Metastasis
Background Gastric metastasis from melanoma is rare and often presents as an unexpected finding, rarely revealing an underlying primary skin melanoma. Case presentation We report a case of a 62-year-old male who presented with abdominal pain, dyspepsia, anorexia, and weight loss. On physical examination abdominal masses and hepatomegaly were detected. Radiological imaging showed widespread masses in the abdominal and thoracic regions. Upper gastrointestinal endoscopy identified an umbilicated protruded lesion with central dark pigmentation at the antro-fundic junction. Histopathological examination and immunohistochemical staining were consistent with melanoma. A subsequent rigorous skin examination uncovered a primary malignant skin melanoma. Due to worsening general condition, the patient received palliative hospice care. Conclusion This report highlights the critical need for vigilant skin examination when dealing with widespread metastatic disease.
- 3 July 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1019
Open AccessCase Report: Overlooked Skin Melanoma Unveiled by Gastric Metastasis
Background Gastric metastasis from melanoma is rare and often presents as an unexpected finding, rarely revealing an underlying primary skin melanoma. Case presentation We report a case of a 62-year-old male who presented with abdominal pain, dyspepsia, anorexia, and weight loss. On physical examination abdominal masses and hepatomegaly were detected. Radiological imaging showed widespread masses in the abdominal and thoracic regions. Upper gastrointestinal endoscopy identified an umbilicated protruded lesion with central dark pigmentation at the antro-fundic junction. Histopathological examination and immunohistochemical staining were consistent with melanoma. A subsequent rigorous skin examination uncovered a primary malignant skin melanoma. Due to worsening general condition, the patient received palliative hospice care. Conclusion This report highlights the critical need for vigilant skin examination when dealing with widespread metastatic disease.
- Open Access
- 7 January 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1019
Case Report: Can You See the Elephant in the Room? Skin Melanoma Revealed by Gastric Metastasis
Background Gastric metastasis from melanoma is rare and often presents as an unexpected finding, rarely revealing an underlying primary skin melanoma. Case presentation We report a case of a 62-year-old male who presented with abdominal pain, dyspepsia, anorexia, and weight loss. On physical examination abdominal masses and hepatomegaly were detected. Radiological imaging showed widespread masses in the abdominal and thoracic regions. Upper gastrointestinal endoscopy identified an umbilicated protruded lesion with central dark pigmentation at the antro-fundic junction. Histopathological examination and immunohistochemical staining were consistent with melanoma. A subsequent rigorous skin examination uncovered a primary malignant skin melanoma. Due to worsening general condition, the patient received palliative hospice care. Conclusion This report highlights the critical need for vigilant skin examination when dealing with widespread metastatic disease.
- 7 January 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1019
Open AccessCase Report: Can You See the Elephant in the Room? Skin Melanoma Revealed by Gastric Metastasis
Background Gastric metastasis from melanoma is rare and often presents as an unexpected finding, rarely revealing an underlying primary skin melanoma. Case presentation We report a case of a 62-year-old male who presented with abdominal pain, dyspepsia, anorexia, and weight loss. On physical examination abdominal masses and hepatomegaly were detected. Radiological imaging showed widespread masses in the abdominal and thoracic regions. Upper gastrointestinal endoscopy identified an umbilicated protruded lesion with central dark pigmentation at the antro-fundic junction. Histopathological examination and immunohistochemical staining were consistent with melanoma. A subsequent rigorous skin examination uncovered a primary malignant skin melanoma. Due to worsening general condition, the patient received palliative hospice care. Conclusion This report highlights the critical need for vigilant skin examination when dealing with widespread metastatic disease.
- Open Access
- 16 December 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1019
Case Report: The Elephant in the Room: Skin Melanoma Unveiled by Gastric Metastasis
Background Gastric metastasis from melanoma is rare and often presents as an unexpected finding, rarely revealing an underlying primary skin melanoma. Case presentation We report a case of a 62-year-old male who presented with abdominal pain, dyspepsia, anorexia, and weight loss. On physical examination abdominal masses and hepatomegaly were detected. Radiological imaging showed widespread masses in the abdominal and thoracic regions. Upper gastrointestinal endoscopy identified an umbilicated protruded lesion with central dark pigmentation at the antro-fundic junction. Histopathological examination and immunohistochemical staining were consistent with melanoma. A subsequent rigorous skin examination uncovered a primary malignant skin melanoma. Due to worsening general condition, the patient received palliative hospice care. Conclusion This report highlights the critical need for vigilant skin examination when encountering gastric lesions with dark pigmentation, which led to the identification of initially undetected cutaneous melanoma.
- 16 December 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1019
Open AccessCase Report: The Elephant in the Room: Skin Melanoma Unveiled by Gastric Metastasis
Background Gastric metastasis from melanoma is rare and often presents as an unexpected finding, rarely revealing an underlying primary skin melanoma. Case presentation We report a case of a 62-year-old male who presented with abdominal pain, dyspepsia, anorexia, and weight loss. On physical examination abdominal masses and hepatomegaly were detected. Radiological imaging showed widespread masses in the abdominal and thoracic regions. Upper gastrointestinal endoscopy identified an umbilicated protruded lesion with central dark pigmentation at the antro-fundic junction. Histopathological examination and immunohistochemical staining were consistent with melanoma. A subsequent rigorous skin examination uncovered a primary malignant skin melanoma. Due to worsening general condition, the patient received palliative hospice care. Conclusion This report highlights the critical need for vigilant skin examination when encountering gastric lesions with dark pigmentation, which led to the identification of initially undetected cutaneous melanoma.
- Open Access
- 6 September 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1019
Case Report: Gastric Metastasis revealing a Disseminated Skin Melanoma: A Case Report and Literature Review
Background Melanoma, an aggressive malignant skin cancer, has the ability to spread both locoregionally and to distant sites. The risk of metastasis is correlated to invasion depth and the presence of ulceration. Although gastrointestinal (GI) metastases are uncommon, gastric involvement is particularly rare. Case presentation We report a case of a 62-year-old male who presented with abdominal pain, dyspepsia, anorexia, and weight loss. On physical examination abdominal masses and hepatomegaly were detected. Radiological imaging showed widespread masses in the abdominal and thoracic regions. Upper GI endoscopy identified an umbilicated protruded lesion with central dark pigmentation at the antro-fundic junction. Histopathological examination and immunohistochemical staining were consistent with melanoma. A subsequent rigorous skin examination uncovered a primary malignant skin melanoma. Due to worsening general condition, the patient received palliative hospice care. Conclusion This report highlights the critical need for vigilant skin examination when encountering gastric lesions with dark pigmentation, which led to the identification of initially undetected cutaneous melanoma.
- 6 September 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1019
Open AccessCase Report: Gastric Metastasis revealing a Disseminated Skin Melanoma: A Case Report and Literature Review
Background Melanoma, an aggressive malignant skin cancer, has the ability to spread both locoregionally and to distant sites. The risk of metastasis is correlated to invasion depth and the presence of ulceration. Although gastrointestinal (GI) metastases are uncommon, gastric involvement is particularly rare. Case presentation We report a case of a 62-year-old male who presented with abdominal pain, dyspepsia, anorexia, and weight loss. On physical examination abdominal masses and hepatomegaly were detected. Radiological imaging showed widespread masses in the abdominal and thoracic regions. Upper GI endoscopy identified an umbilicated protruded lesion with central dark pigmentation at the antro-fundic junction. Histopathological examination and immunohistochemical staining were consistent with melanoma. A subsequent rigorous skin examination uncovered a primary malignant skin melanoma. Due to worsening general condition, the patient received palliative hospice care. Conclusion This report highlights the critical need for vigilant skin examination when encountering gastric lesions with dark pigmentation, which led to the identification of initially undetected cutaneous melanoma.
- Open Access
- 1 September 2023
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 686
EncephalApp Stroop Test for covert hepatic encephalopathy screening in Tunisian cirrhotic patients
Background: Covert hepatic encephalopathy (CHE) is underdiagnosed and is difficult to detect. The EncephalApp Stroop test is validated for its screening. The aim of the study was to define Tunisian norms for the test based on healthy controls norms and to estimate the prevalence of CHE in cirrhotic Tunisian patients. Methods: A prospective, multicenter, cross‐sectional study was conducted. Ambulatory or hospitalized cirrhotic patients aged 40 years and over were recruited at 11 centers. Healthy subjects aged 40 years and over were recruited at 8 centers. We used a translated Arabic version of the streamlined EncephalApp Stroop test. The task has two components: “Off” and “On” state depending on the discordance or concordance of the stimuli. Results: 142 patients were included. The mean age was 57.26 years [40–86]. 40 (28.17%) of cirrhotic patients who were included were diagnosed as having a minimal hepatic encephalopathy or CHE. Among the ineligible patients, 22 had overt hepatic encephalopathy. If we consider these patients, the overall prevalence rate of CHE was around 24.39% in cirrhotic patients. It was more frequent in women (34.21% vs 25.96%), and in patients whose level of school education is between 6 and 13 years. Its prevalence does not appear to be affected by gender, MELD score, etiology of cirrhosis and age group of patients, as these variables were independent with respective p according to the chi-square test 0.413; 0.736; 0.663 and 0.1. The stroop times (On / Off and On + Off) correlated significantly with each other, are associated significantly and positively with age (respective Pearson coefficients: 0.578; 0.567 and 0.6). The more the age increases, the more the stroop response times increases (p > 10-3). Conclusions: EncephalApp Stroop test was an efficient screening tool for CHE in Tunisian cirrhotic patients.
- 1 September 2023
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 686
Open AccessEncephalApp Stroop Test for covert hepatic encephalopathy screening in Tunisian cirrhotic patients
Background: Covert hepatic encephalopathy (CHE) is underdiagnosed and is difficult to detect. The EncephalApp Stroop test is validated for its screening. The aim of the study was to define Tunisian norms for the test based on healthy controls norms and to estimate the prevalence of CHE in cirrhotic Tunisian patients. Methods: A prospective, multicenter, cross‐sectional study was conducted. Ambulatory or hospitalized cirrhotic patients aged 40 years and over were recruited at 11 centers. Healthy subjects aged 40 years and over were recruited at 8 centers. We used a translated Arabic version of the streamlined EncephalApp Stroop test. The task has two components: “Off” and “On” state depending on the discordance or concordance of the stimuli. Results: 142 patients were included. The mean age was 57.26 years [40–86]. 40 (28.17%) of cirrhotic patients who were included were diagnosed as having a minimal hepatic encephalopathy or CHE. Among the ineligible patients, 22 had overt hepatic encephalopathy. If we consider these patients, the overall prevalence rate of CHE was around 24.39% in cirrhotic patients. It was more frequent in women (34.21% vs 25.96%), and in patients whose level of school education is between 6 and 13 years. Its prevalence does not appear to be affected by gender, MELD score, etiology of cirrhosis and age group of patients, as these variables were independent with respective p according to the chi-square test 0.413; 0.736; 0.663 and 0.1. The stroop times (On / Off and On + Off) correlated significantly with each other, are associated significantly and positively with age (respective Pearson coefficients: 0.578; 0.567 and 0.6). The more the age increases, the more the stroop response times increases (p > 10-3). Conclusions: EncephalApp Stroop test was an efficient screening tool for CHE in Tunisian cirrhotic patients.
- Open Access
- 7 November 2022
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 654
Case Report: Severe gastrointestinal bleeding revealing metastatic multifocal gastrointestinal angiosarcoma
Background: Angiosarcoma is a rare soft-tissue sarcoma that can arise in any soft-tissue structure or viscera. Only individual case reports and small series of gastrointestinal angiosarcoma have been reported in the literature. In this paper, we report the first African case of small intestine epithelioid angiosarcoma. Case report: Here, we present the case of a 66-year-old man who presented with melena and anemia. Physical examination showed the presence of two subcutaneous masses on the right and left flanks. Esophagogastroduodenoscopy, duodenoscopy and jejunoscopy revealed multiple purpuric and hemorrhagic nodules and masses, some of which were bleeding. Pathological study of the ampullary formation and of a subcutaneous nodule concluded to the diagnosis of epithelioid angiosarcoma. Blood transfusions and interventional endoscopy by argan plasma coagulation were required due to a continued drop in hemoglobin. A drop in hemoglobin persisted and the patient died within 10 days. Conclusions: Angiosarcoma has a very poor prognosis due to delayed prognosis and insufficient therapeutic management. Interventional endoscopy to control bleeding can be considered in localized forms. Chemotherapy may help to prolong survival in metastatic and disseminated angiosarcoma. Further studies should be conducted to improve the prognosis.
- 7 November 2022
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 654
Open AccessCase Report: Severe gastrointestinal bleeding revealing metastatic multifocal gastrointestinal angiosarcoma
Background: Angiosarcoma is a rare soft-tissue sarcoma that can arise in any soft-tissue structure or viscera. Only individual case reports and small series of gastrointestinal angiosarcoma have been reported in the literature. In this paper, we report the first African case of small intestine epithelioid angiosarcoma. Case report: Here, we present the case of a 66-year-old man who presented with melena and anemia. Physical examination showed the presence of two subcutaneous masses on the right and left flanks. Esophagogastroduodenoscopy, duodenoscopy and jejunoscopy revealed multiple purpuric and hemorrhagic nodules and masses, some of which were bleeding. Pathological study of the ampullary formation and of a subcutaneous nodule concluded to the diagnosis of epithelioid angiosarcoma. Blood transfusions and interventional endoscopy by argan plasma coagulation were required due to a continued drop in hemoglobin. A drop in hemoglobin persisted and the patient died within 10 days. Conclusions: Angiosarcoma has a very poor prognosis due to delayed prognosis and insufficient therapeutic management. Interventional endoscopy to control bleeding can be considered in localized forms. Chemotherapy may help to prolong survival in metastatic and disseminated angiosarcoma. Further studies should be conducted to improve the prognosis.
- Open Access
A Rare MSH2 Variant as a Candidate Marker for Lynch Syndrome II Screening in Tunisia: A Case of Diffuse Gastric Carcinoma
Several syndromic forms of digestive cancers are known to predispose to early-onset gastric tumors such as Hereditary Diffuse Gastric Cancer (HDGC) and Lynch Syndrome (LS). LSII is an extracolonic cancer syndrome characterized by a tumor spectrum including gastric cancer (GC). In the current work, our main aim was to identify the mutational spectrum underlying the genetic predisposition to diffuse gastric tumors occurring in a Tunisian family suspected of both HDGC and LS II syndromes. We selected the index case “JI-021”, which was a woman diagnosed with a Diffuse Gastric Carcinoma and fulfilling the international guidelines for both HDGC and LSII syndromes. For DNA repair, a custom panel targeting 87 candidate genes recovering the four DNA repair pathways was used. Structural bioinformatics analysis was conducted to predict the effect of the revealed variants on the functional properties of the proteins. DNA repair genes panel screening identified two variants: a rare MSH2 c.728G>A classified as a variant with uncertain significance (VUS) and a novel FANCD2 variant c.1879G>T. The structural prediction model of the MSH2 variant and electrostatic potential calculation showed for the first time that MSH2 c.728G>A is likely pathogenic and is involved in the MSH2-MLH1 complex stability. It appears to affect the MSH2-MLH1 complex as well as DNA-complex stability. The c.1879G>T FANCD2 variant was predicted to destabilize the protein structure. Our results showed that the MSH2 p.R243Q variant is likely pathogenic and is involved in the MSH2-MLH1 complex stability, and molecular modeling analysis highlights a putative impact on the binding with MLH1 by disrupting the electrostatic potential, suggesting the revision of its status from VUS to likely pathogenic. This variant seems to be a shared variant in the Mediterranean region. These findings emphasize the importance of testing DNA repair genes for patients diagnosed with diffuse GC with suspicion of LSII and colorectal cancer allowing better clinical surveillance for more personalized medicine.
Open AccessA Rare MSH2 Variant as a Candidate Marker for Lynch Syndrome II Screening in Tunisia: A Case of Diffuse Gastric Carcinoma
Several syndromic forms of digestive cancers are known to predispose to early-onset gastric tumors such as Hereditary Diffuse Gastric Cancer (HDGC) and Lynch Syndrome (LS). LSII is an extracolonic cancer syndrome characterized by a tumor spectrum including gastric cancer (GC). In the current work, our main aim was to identify the mutational spectrum underlying the genetic predisposition to diffuse gastric tumors occurring in a Tunisian family suspected of both HDGC and LS II syndromes. We selected the index case “JI-021”, which was a woman diagnosed with a Diffuse Gastric Carcinoma and fulfilling the international guidelines for both HDGC and LSII syndromes. For DNA repair, a custom panel targeting 87 candidate genes recovering the four DNA repair pathways was used. Structural bioinformatics analysis was conducted to predict the effect of the revealed variants on the functional properties of the proteins. DNA repair genes panel screening identified two variants: a rare MSH2 c.728G>A classified as a variant with uncertain significance (VUS) and a novel FANCD2 variant c.1879G>T. The structural prediction model of the MSH2 variant and electrostatic potential calculation showed for the first time that MSH2 c.728G>A is likely pathogenic and is involved in the MSH2-MLH1 complex stability. It appears to affect the MSH2-MLH1 complex as well as DNA-complex stability. The c.1879G>T FANCD2 variant was predicted to destabilize the protein structure. Our results showed that the MSH2 p.R243Q variant is likely pathogenic and is involved in the MSH2-MLH1 complex stability, and molecular modeling analysis highlights a putative impact on the binding with MLH1 by disrupting the electrostatic potential, suggesting the revision of its status from VUS to likely pathogenic. This variant seems to be a shared variant in the Mediterranean region. These findings emphasize the importance of testing DNA repair genes for patients diagnosed with diffuse GC with suspicion of LSII and colorectal cancer allowing better clinical surveillance for more personalized medicine.
- Open Access
- 21 June 2022
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 686
EncephalApp Stroop Test for covert hepatic encephalopathy screening in Tunisian cirrhotic patients
Background: Covert hepatic encephalopathy (CHE) is underdiagnosed and is difficult to detect. The EncephalApp Stroop test is validated for its screening. The aim of the study was to define Tunisian norms for the test based on healthy controls norms and to estimate the prevalence of CHE in cirrhotic Tunisian patients. Methods: A prospective, multicenter, cross‐sectional study was conducted. Ambulatory or hospitalized cirrhotic patients aged 40 years and over were recruited at 11 centers. Healthy subjects aged 40 years and over were recruited at 8 centers. We used a translated Arabic version of the streamlined EncephalApp Stroop test. The task has two components: “Off” and “On” state depending on the discordance or concordance of the stimuli. Results: 142 patients were included. The mean age was 57.26 years [40–86]. 40 (28.17%) of cirrhotic patients who were included were diagnosed as having a minimal hepatic encephalopathy or CHE. Among the ineligible patients, 22 had overt hepatic encephalopathy. If we consider these patients, the overall prevalence rate of CHE was around 24.39% in cirrhotic patients. It was more frequent in women (34.21% vs 25.96%), and in patients whose level of school education is between 6 and 13 years. Its prevalence does not appear to be affected by gender, MELD score, etiology of cirrhosis and age group of patients, as these variables were independent with respective p according to the chi-square test 0.413; 0.736; 0.663 and 0.1. The stroop times (On / Off and On + Off) correlated significantly with each other, are associated significantly and positively with age (respective Pearson coefficients: 0.578; 0.567 and 0.6). The more the age increases, the more the stroop response times increases (p > 10-3). Conclusions: EncephalApp Stroop test was an efficient screening tool for CHE in Tunisian cirrhotic patients.
- 21 June 2022
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 686
Open AccessEncephalApp Stroop Test for covert hepatic encephalopathy screening in Tunisian cirrhotic patients
Background: Covert hepatic encephalopathy (CHE) is underdiagnosed and is difficult to detect. The EncephalApp Stroop test is validated for its screening. The aim of the study was to define Tunisian norms for the test based on healthy controls norms and to estimate the prevalence of CHE in cirrhotic Tunisian patients. Methods: A prospective, multicenter, cross‐sectional study was conducted. Ambulatory or hospitalized cirrhotic patients aged 40 years and over were recruited at 11 centers. Healthy subjects aged 40 years and over were recruited at 8 centers. We used a translated Arabic version of the streamlined EncephalApp Stroop test. The task has two components: “Off” and “On” state depending on the discordance or concordance of the stimuli. Results: 142 patients were included. The mean age was 57.26 years [40–86]. 40 (28.17%) of cirrhotic patients who were included were diagnosed as having a minimal hepatic encephalopathy or CHE. Among the ineligible patients, 22 had overt hepatic encephalopathy. If we consider these patients, the overall prevalence rate of CHE was around 24.39% in cirrhotic patients. It was more frequent in women (34.21% vs 25.96%), and in patients whose level of school education is between 6 and 13 years. Its prevalence does not appear to be affected by gender, MELD score, etiology of cirrhosis and age group of patients, as these variables were independent with respective p according to the chi-square test 0.413; 0.736; 0.663 and 0.1. The stroop times (On / Off and On + Off) correlated significantly with each other, are associated significantly and positively with age (respective Pearson coefficients: 0.578; 0.567 and 0.6). The more the age increases, the more the stroop response times increases (p > 10-3). Conclusions: EncephalApp Stroop test was an efficient screening tool for CHE in Tunisian cirrhotic patients.
- Open Access
- 14 June 2022
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 654
Case Report: Severe gastrointestinal bleeding revealing metastatic multifocal gastrointestinal angiosarcoma
Background: Angiosarcoma is a rare soft-tissue sarcoma that can arise in any soft-tissue structure or viscera. Only individual case reports and small series of gastrointestinal angiosarcoma have been reported in the literature. In this paper, we report the first African case of small intestine epithelioid angiosarcoma. Case report: Here, we present the case of a 66-year-old man who presented with melena and anemia. Physical examination showed the presence of two subcutaneous masses on the right and left flanks. Esophagogastroduodenoscopy, duodenoscopy and jejunoscopy revealed multiple purpuric and hemorrhagic nodules and masses, some of which were bleeding. Pathological study of the ampullary formation and of a subcutaneous nodule concluded to the diagnosis of epithelioid angiosarcoma. Blood transfusions and interventional endoscopy by argan plasma coagulation were required due to a continued drop in hemoglobin. A drop in hemoglobin persisted and the patient died within 10 days. Conclusions: Angiosarcoma has a very poor prognosis due to delayed prognosis and insufficient therapeutic management. Interventional endoscopy to control bleeding can be considered in localized forms. Chemotherapy may help to prolong survival in metastatic and disseminated angiosarcoma. Further studies should be conducted to improve the prognosis.
- 14 June 2022
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 654
Open AccessCase Report: Severe gastrointestinal bleeding revealing metastatic multifocal gastrointestinal angiosarcoma
Background: Angiosarcoma is a rare soft-tissue sarcoma that can arise in any soft-tissue structure or viscera. Only individual case reports and small series of gastrointestinal angiosarcoma have been reported in the literature. In this paper, we report the first African case of small intestine epithelioid angiosarcoma. Case report: Here, we present the case of a 66-year-old man who presented with melena and anemia. Physical examination showed the presence of two subcutaneous masses on the right and left flanks. Esophagogastroduodenoscopy, duodenoscopy and jejunoscopy revealed multiple purpuric and hemorrhagic nodules and masses, some of which were bleeding. Pathological study of the ampullary formation and of a subcutaneous nodule concluded to the diagnosis of epithelioid angiosarcoma. Blood transfusions and interventional endoscopy by argan plasma coagulation were required due to a continued drop in hemoglobin. A drop in hemoglobin persisted and the patient died within 10 days. Conclusions: Angiosarcoma has a very poor prognosis due to delayed prognosis and insufficient therapeutic management. Interventional endoscopy to control bleeding can be considered in localized forms. Chemotherapy may help to prolong survival in metastatic and disseminated angiosarcoma. Further studies should be conducted to improve the prognosis.
- Open Access
- 20 March 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (3) , e05634
Acquired double pylorus presenting as a gastrointestinal bleeding
We present the case of a 65‐year‐old man without a past medical history who was admitted for gastrointestinal bleeding. The case shows an acquired double pylorus due to probable pre pyloric ulcer.
- 20 March 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (3) , e05634
Open AccessAcquired double pylorus presenting as a gastrointestinal bleeding
We present the case of a 65‐year‐old man without a past medical history who was admitted for gastrointestinal bleeding. The case shows an acquired double pylorus due to probable pre pyloric ulcer.